Market OverviewThe global transrectal ultrasound (TRUS) market is expected to grow at a steady CAGR of around 6% during the forecast period. The market growth is driven by the rising prevalence of ...

Exact Imaging today announced results from its OPTIMUM clinical trial demonstrating the non-inferiority of its ExactVu(TM) micro-ultrasound platform to MRI fusion-guided biopsy for diagnosing prostate ...

Patients with the deadliest form of brain cancer, glioblastoma, who received MRI-guided focused ultrasound with ...

Discover how transperineal prostate biopsy under local anaesthesia delivers high diagnostic yield safely and without ...

Study data, published in JAMA and presented at EMUC 2025, suggest ExactVu is potential MRI alternative for image-guided prostate biopsy Exact Imaging today announced results from its OPTIMUM clinical ...

Combined efficacy of chemotherapy and ultrasound found to elevate brain cancer survival by 40%, making medications work ...

Patients with the deadliest form of brain cancer, glioblastoma, who received MRI-guided focused ultrasound with ...

Non-invasive and targeted transcranial focused ultrasound (FUS) treatments combined with systemically administered ...

This guide provides an informative and educational overview of stage 3 papillary thyroid cancer (PTC) to help drive a ...